Related Experiment Videos
Optimizing breast pocket irrigation: an in vitro study and clinical implications.
W P Adams1, W C Conner, F E Barton
1Department of Plastic and Reconstructive Surgery, University of Texas Southwestern Medical Center, Dallas 75235, USA. wadam1@mednet.swmed.edu
Plastic and Reconstructive Surgery
|January 8, 2000
Summary
Subclinical infections may cause capsular contracture. Combining 10% povidone-iodine with gentamicin/cefazolin effectively kills common breast implant bacteria, potentially reducing contracture incidence.
Area of Science:
- Microbiology
- Infectious Diseases
- Plastic Surgery
Background:
- Subclinical infections are linked to capsular contracture after breast implantation.
- Intraoperative breast pocket irrigation with antiseptic solutions is common, but potential negative effects on wound healing and efficacy against specific bacteria are not well-established.
Purpose of the Study:
- To compare the in vitro efficacy of povidone-iodine and antibiotic solutions against common breast implant-associated bacteria.
- To evaluate novel combinations for improved bacterial control and reduced wound healing impact.
Main Methods:
- Phase I: In vitro testing of serial dilutions of povidone-iodine and double antibiotic solutions (DAB-1: gentamicin/polymyxin B; DAB-2: gentamicin/cefazolin) against five common organisms.
- Phase II: Povidone-iodine diluted in DAB-1.
- Phase III: Povidone-iodine diluted in DAB-2.
- Efficacy determined by bacterial culture growth after incubation.
Main Results:
- Povidone-iodine alone showed variable efficacy: 100% effective at 12.5% against Staphylococcus epidermidis, 25% against Staphylococcus aureus, but less effective against Escherichia coli and Pseudomonas.
- DAB-1 was ineffective against S. epidermidis but effective against S. aureus, Propionibacterium acnes, E. coli, and Pseudomonas.
- A 12.5% povidone-iodine concentration in DAB-1 (Phase II) and 10% in DAB-2 (Phase III) effectively killed all tested bacteria.
Conclusions:
- Combining 10% povidone-iodine with gentamicin/cefazolin (DAB-2) demonstrates excellent in vitro efficacy against common breast implant-associated bacteria.
- This combination may offer enhanced bacterial control while minimizing adverse effects on wound healing, potentially reducing capsular contracture incidence.